Clinical trial
Randomised, Double-Blind, Placebo Controlled Study of the Antipyretic Effect of Ibuprofen in Children With Uncomplicated Malaria
NCT00167713 is registered in ClinicalTrials.gov with Albert Schweitzer Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomised, Double-Blind, Placebo Controlled Study of the Antipyretic Effect of Ibuprofen in Children With Uncomplicated Malaria
- Lead sponsor
- Albert Schweitzer Hospital
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- April 30, 2003
- Completion date
- January 31, 2004
- Enrollment
- 50
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.